We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS OIG ISSUES SEMIANNUAL REPORT HIGHLIGHTING ACCOMPLISHMENTS
The HHS' Office of Inspector General (OIG) has highlighted recent accomplishments, including securing a $430 million settlement from Pfizer's Warner-Lambert unit to resolve allegations that it caused the submission of false and/or fraudulent claims to Medicaid through off-label marketing of the epilepsy drug Neurontin (gabapentin).